Inari Shares Skyrocket

Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Key Takeaways Shares of Inari Medical surged Monday afternoon and again Tuesday morning as reports of an imminent acquisition by Stryker turned into reality.Stryker will acquire Inari in an all-cash deal for $80 per share,
Stryker agrees to acquire Inari Medical for $4.9bn
Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of nearly $4.9bn. Inari is poised to enhance Stryker's footprint in the peripheral vascular sector, particularly in the venous thromboembolism (VTE) market.
Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an approximate value of $4.9 billion.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Inari Getting Acquired by Stryker for $4.9B
Irvine-based Inari Medical Inc. has entered into an agreement to be acquired for $4.9 billion by medical technology company Stryker Corp.
Stryker to acquire Inari Medical for $4.9B
Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
Stryker Corporation SYK recently inked a definitive agreement to acquire all the issued and outstanding shares of common stock of Inari Medical, Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.
Inari Medical soars on Stryker acquisition
Inari Medical Inc (NASDAQ:NARI) shares surged sharply after Stryker (NYSE:SYK) announced that it would acquire the medical device maker in an all-cash deal valued at $4.9 billion The acquisition strengthens Stryker’s position
Stryker to Buy Inari Medical in $4.9 Billion Deal
Stryker (SYK) agreed to acquire medical technology maker Inari Medical (NARI) in an all-cash deal worth roughly $4.9 billion as the company looks to boost its neurovascular and endovascular segments.
Ag Funder News2d
Seed gene-editing startup Inari eyes commercialization with $144m round: ‘It puts us in a robust financial position’
Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.
Cambridge agtech startup Inari raises equity at $2.17 billion valuation
Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a ...
Inari raises $144M as Corteva lawsuit proceeds
Cambridge-based seed design company Inari Agriculture raised one of the first late-stage venture rounds of 2025.
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...
5 Things to Know Before the Stock Market Opens
U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...